Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

FXYD6 Inhibitors

FXYD6 inhibitors constitute a distinctive class of chemical compounds with a targeted purpose: to selectively engage with and influence the function of the FXYD6 protein. Also recognized as phosphohippolin, FXYD6 holds a prominent position within the FXYD family of membrane proteins. The design of these inhibitors is a meticulous process, meticulously tailoring their molecular structures to establish specific and meaningful interactions with FXYD6. The objective is to modulate its function and, in turn, its role in the intricate realm of ion transport regulation. By delicately intervening in the complex interplay surrounding FXYD6, these inhibitors carry the ability to exert a nuanced impact on ion channels and the vital processes of membrane transport. The development journey of FXYD6 inhibitors traverses a multifaceted landscape. It involves an intricate fusion of molecular modeling, rigorous structural analyses, and comprehensive biochemical assays. Such a comprehensive approach is pivotal to ensure that these inhibitors possess the precision and potency required for their tailored engagement with FXYD6. The scientific inquiry within this field seeks to plumb the depths of molecular mechanisms governing ion transport dynamics and the intricacies of membrane organization. The goal is to shed light on the interplay between FXYD6 and ion channels, as well as the consequential effects on cellular equilibrium and the signaling pathways contingent upon the orchestration of ion transport processes.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ouabain Octahydrate

11018-89-6sc-201548
sc-201548A
1 g
5 g
$190.00
$720.00
11
(2)

Ouabain is another cardiac glycoside that inhibits Na+/K+-ATPase activity and affects ion transport.

12β-Hydroxydigitoxin

20830-75-5sc-213604
sc-213604A
1 g
5 g
$140.00
$680.00
(0)

12β-Hydroxydigitoxin is a well-known cardiac glycoside that inhibits Na+/K+-ATPase activity, leading to increased intracellular sodium levels and altered ion transport.

Aldosterone

52-39-1sc-210774
sc-210774A
sc-210774B
sc-210774C
sc-210774D
sc-210774E
2 mg
5 mg
10 mg
50 mg
100 mg
250 mg
$254.00
$209.00
$311.00
$1520.00
$3014.00
$7487.00
1
(1)

Aldosterone regulates Na+/K+-ATPase expression and activity, potentially influencing FXYD6.

Hydrocortisone

50-23-7sc-300810
5 g
$100.00
6
(1)

Cortisol can influence electrolyte balance and Na+/K+-ATPase activity, possibly impacting FXYD6 function.

Insulin

11061-68-0sc-29062
sc-29062A
sc-29062B
100 mg
1 g
10 g
$153.00
$1224.00
$12239.00
82
(1)

Insulin can modulate Na+/K+-ATPase activity, which might indirectly affect FXYD6's role.

Dopamine

51-61-6sc-507336
1 g
$290.00
(0)

Dopamine can influence Na+/K+-ATPase activity, potentially affecting FXYD6 function.

Angiotensin II, Human

4474-91-3sc-363643
sc-363643A
sc-363643B
sc-363643C
1 mg
5 mg
25 mg
100 mg
$50.00
$75.00
$260.00
$505.00
3
(1)

Angiotensin II, through its regulatory effects on electrolyte balance, can influence Na+/K+-ATPase and potentially FXYD6.

ADP

58-64-0sc-507362
5 g
$53.00
(0)

ATP is the primary energy source for Na+/K+-ATPase, and its availability can indirectly influence FXYD6 function.